References:
  1. Buyse S, Teixeira L, Galicier L,Mariotte E, Lemiale V, Seguin A, et al. Critical caremanagement of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 2010;36(10):1695–702.
  2. A Hayden, S Park, D Giustini, A Y.Y. Lee, L Y.C. Chen. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review. Blood Reviews 2016;30(6): 411–420
  3. Risdall RJ, McKenna RW, Nesbit ME et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44: 993-1002.
  4. O. Lambotte, F. Méchai. Hemophagocytic syndrome. La Lettre de l’Infectiologue - Tome XXII - n° 3 - mai-juin 2007
  5. zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 2005;14(6):827–34.
  6. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005;135(21– 22):299–314.
  7. Ramos-Casals M, Brito-ZerÓn P, LÓpez- Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014; 383(9927):1503-1516.
  8. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7(12): 814-822.
  9. Henter JI, Horne A, AricÓ M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131.
  10. Bergsten E, Horne A, AricÓ M, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728-2738.
  11. P. La Rosée, A. Horne, M. Hines, T von Bahr Greenwood, R. Machowicz, N. Berliner, S. Birndt, J. Gil-Herrera. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019; 133 (23).
  12. V Kollipara, S Hussain, D Franco-Palacios, U Sofi. A case series of endemic infections associated hemophagocytic lymphohistiocytosis (HLH) mimicking severe sepsis syndrome. Respir Med Case Rep. 2019; 27: 100854
  13. Machowicz R, Janka G, Wiktor-Jedrzejczak W. Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis). Crit Care. 2016;20(1):215.
  14. Mavilia MG, Wu GY. HBV-HCV coinfection: viral interactions, management, and viral reactivation. J Clin Transl Hepatol 2018;6(3):296–305. doi: 10.14218/JCTH.2018.00016.
  15. Pol S, Haour G, Fontaine H, Dorival C, Petrov-Sanchez V, Bourliere M, et al. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Aliment Pharmacol Ther 2017;46:1054–1060. doi: 10.1111/apt.14352.
  16. Yang WT, Wu LW, Tseng TC, Chen CL, Yang HC, Su TH, et al. Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection. Medicine (Baltimore) 2016;95:e2995. doi: 10.1097/MD.0000000000002995.
  17. Calvaruso V, Ferraro D, Licata A, Bavetta MG, Petta S, Bronte F, et al. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with directacting antivirals. J Viral Hepat 2018;25:72–79. doi: 10.1111/jvh.12754.
  18. Machowicz R, Janka G, Wiktor-Jedrzejczak W. Similar but not the same: differential diagnosis of HLH and sepsis. Crit Rev Oncol Hematol. 2017; 114:1-12.
  19. Jordan MB, Allen CE, Weitzman S, lipovich AH, et coll. How i treat hemophagocytic lymphohistiocytosis. Blood 2011; 118 (15): 4041-4052.